Aadi Bioscience (AADI) Competitors $1.80 +0.03 (+1.69%) As of 08/6/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AADI vs. LYEL, ACRS, SLS, CLLS, VYGR, DERM, CTOR, LFVN, LIMN, and CTNMShould you be buying Aadi Bioscience stock or one of its competitors? The main competitors of Aadi Bioscience include Lyell Immunopharma (LYEL), Aclaris Therapeutics (ACRS), SELLAS Life Sciences Group (SLS), Cellectis (CLLS), Voyager Therapeutics (VYGR), Journey Medical (DERM), Citius Oncology (CTOR), Lifevantage (LFVN), Liminatus Pharma (LIMN), and Contineum Therapeutics (CTNM). These companies are all part of the "pharmaceutical products" industry. Aadi Bioscience vs. Its Competitors Lyell Immunopharma Aclaris Therapeutics SELLAS Life Sciences Group Cellectis Voyager Therapeutics Journey Medical Citius Oncology Lifevantage Liminatus Pharma Contineum Therapeutics Lyell Immunopharma (NASDAQ:LYEL) and Aadi Bioscience (NASDAQ:AADI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership. Do institutionals and insiders have more ownership in LYEL or AADI? 66.1% of Lyell Immunopharma shares are held by institutional investors. Comparatively, 52.1% of Aadi Bioscience shares are held by institutional investors. 22.3% of Lyell Immunopharma shares are held by company insiders. Comparatively, 37.3% of Aadi Bioscience shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has stronger earnings and valuation, LYEL or AADI? Aadi Bioscience has higher revenue and earnings than Lyell Immunopharma. Aadi Bioscience is trading at a lower price-to-earnings ratio than Lyell Immunopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLyell Immunopharma$65K2,691.90-$342.99M-$25.00-0.45Aadi Bioscience$25.07M1.77-$65.76M-$2.35-0.77 Which has more volatility and risk, LYEL or AADI? Lyell Immunopharma has a beta of -0.19, suggesting that its stock price is 119% less volatile than the S&P 500. Comparatively, Aadi Bioscience has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Is LYEL or AADI more profitable? Aadi Bioscience has a net margin of -246.06% compared to Lyell Immunopharma's net margin of -514,649.22%. Aadi Bioscience's return on equity of -71.87% beat Lyell Immunopharma's return on equity.Company Net Margins Return on Equity Return on Assets Lyell Immunopharma-514,649.22% -73.66% -60.99% Aadi Bioscience -246.06%-71.87%-57.28% Do analysts recommend LYEL or AADI? Lyell Immunopharma currently has a consensus price target of $15.00, indicating a potential upside of 32.51%. Aadi Bioscience has a consensus price target of $1.67, indicating a potential downside of 7.41%. Given Lyell Immunopharma's higher probable upside, research analysts clearly believe Lyell Immunopharma is more favorable than Aadi Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lyell Immunopharma 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Aadi Bioscience 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media refer more to LYEL or AADI? In the previous week, Lyell Immunopharma's average media sentiment score of 0.00 equaled Aadi Bioscience'saverage media sentiment score. Company Overall Sentiment Lyell Immunopharma Neutral Aadi Bioscience Neutral SummaryAadi Bioscience beats Lyell Immunopharma on 9 of the 13 factors compared between the two stocks. Get Aadi Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for AADI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AADI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AADI vs. The Competition Export to ExcelMetricAadi BiosciencePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$44.46M$785.27M$5.48B$9.57BDividend YieldN/A4.84%3.99%4.18%P/E Ratio-0.791.2929.8725.14Price / Sales1.7725.43422.9397.17Price / CashN/A19.5635.9458.58Price / Book0.426.578.105.59Net Income-$65.76M-$3.92M$3.26B$265.48M7 Day Performance2.86%-2.83%0.64%1.22%1 Month Performance-9.09%-0.30%2.42%0.39%1 Year Performance33.33%23.98%27.60%23.47% Aadi Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AADIAadi Bioscience0.4667 of 5 stars$1.80+1.7%$1.67-7.4%+33.3%$44.46M$25.07M-0.7940LYELLyell Immunopharma3.3284 of 5 stars$11.37+3.2%$15.00+31.9%-59.9%$170.34M$60K-0.45270ACRSAclaris Therapeutics2.0212 of 5 stars$1.56+2.0%$8.71+458.6%+31.9%$165.67M$18.72M-1.12100News CoverageEarnings ReportSLSSELLAS Life Sciences Group2.233 of 5 stars$1.59-4.2%$7.00+340.3%+36.8%$165.63M$1M-4.1810Upcoming EarningsCLLSCellectis2.2194 of 5 stars$3.02+2.4%$4.00+32.5%+31.0%$163.97M$49.22M-3.51290Earnings ReportGap UpVYGRVoyager Therapeutics3.9207 of 5 stars$3.21+8.4%$13.39+317.1%-54.3%$163.80M$80M-2.20100Analyst ForecastHigh Trading VolumeDERMJourney Medical1.7306 of 5 stars$7.14+2.1%$9.50+33.1%+48.4%$162.84M$56.13M-18.3190News CoverageUpcoming EarningsCTORCitius Oncology1.0606 of 5 stars$2.06flat$3.00+45.6%N/A$161.44MN/A0.00N/ALFVNLifevantage4.0702 of 5 stars$13.29+5.6%$30.50+129.5%+72.5%$158.36M$200.16M19.26260LIMNLiminatus PharmaN/A$5.09-14.2%N/AN/A$154.27MN/A0.00N/ACTNMContineum Therapeutics2.4425 of 5 stars$5.80-2.7%$22.50+287.9%-60.1%$154.19M$50M-2.9431Earnings ReportUpcoming Earnings Related Companies and Tools Related Companies LYEL Competitors ACRS Competitors SLS Competitors CLLS Competitors VYGR Competitors DERM Competitors CTOR Competitors LFVN Competitors LIMN Competitors CTNM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AADI) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aadi Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aadi Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AADI Stock Alerts